UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 696

Sortiert nach

120 Chemokine receptor engineering enhances trafficking and homing of primary and iPSC-derived CAR-T cells to solid tumors

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A129-A129

2021

Volltextzugriff (PDF)

1290: PSA Velocity in BPH: Characteristics and its Value to Predict BPH-Related Invasive Therapy

The Journal of urology, 2005-04, Vol.173 (4), p.350-350

2005

Volltextzugriff (PDF)

138 Synthetic re-direction of TGFβ receptors as a novel strategy to enhance the anti-tumor activity of CAR-T cells in solid tumors

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A147-A147

2021

Volltextzugriff (PDF)

1552: Surgical and Medical Retreatment Rates After Watchful Waiting in Patients With Luts Due to BPH

The Journal of urology, 2004-04, Vol.171 (4), p.409-409

2004

Volltextzugriff (PDF)

358 PERCUTANEOUS NEPHROLITHOTOMY USING SPINAL ANESTHESIA: SAFETY AND EFFICACY

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.136-136

2010

Volltextzugriff (PDF)

415Large postvoid residual urine volumes: Does it affect clinical progression of treated and untreated BPH?

European urology supplements : official journal of the European Association of Urology, 2005-03, Vol.4 (3), p.106-106

2005

Volltextzugriff (PDF)

558 Results of a prospective study in 110 patients with lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH) using a nitinol thermo-expandable hour-glass shaped prostatic stent

European urology supplements : official journal of the European Association of Urology, 2004-02, Vol.3 (2), p.142-142

2004

Volltextzugriff (PDF)

559 The use of a nitinol thermo-expandable bell-shaped prostatic stent in benign prostatic hyperplasia (BPH): A feasibility study

European urology supplements : official journal of the European Association of Urology, 2004-02, Vol.3 (2), p.142-142

2004

Volltextzugriff (PDF)

Abstract 1497: A unique strategy to arm iPSC-derived CAR-T cells to perform antibody-directed cellular cytotoxicity to facilitate multi-antigen targeting

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1497-1497

2021

Volltextzugriff (PDF)

Abstract 1591: FT536: Preclinical development of a novel off-the-shelf CAR-MICA/B NK cell immunotherapy combined with radiation and antibody treatments as a first-of-kind pan-cancer targeting strategy

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1591-1591

2021

Volltextzugriff (PDF)

Abstract 2756: Multiplexed-engineered, iPSC-derived T cells expressing three unique targeting modalities address tumor heterogeneity and antigen escape

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2756-2756

2022

Volltextzugriff (PDF)

Abstract 2761: FT573: Preclinical development of multiplexed-engineered iPSC-derived NK cells expressing a novel camelid nanobody chimeric antigen receptor (CAR) targeting pan-cancer antigen B7-H3

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2761-2761

2022

Volltextzugriff (PDF)

Abstract 3245: FT819 path to IND: First-of-kind off-the-shelf CAR19 T-cell for B cell malignancies

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3245-3245

2020

Volltextzugriff (PDF)

Abstract LB-073: Generation of novel single cell-derived engineered master pluripotent cell line as a renewable source for off-the-shelf TCR-less CAR T cells in support of first-of-kind clinical trial

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.LB-073-LB-073

2019

Volltextzugriff (PDF)

Accurate prediction of need for invasive treatment in alpha 1-blocker treated patients with benign prostatic hyperplasia not possible: Bootstrap validation analysis

Urology (Ridgewood, N.J.), 2006, Vol.67 (5), p.984-989

2006

Volltextzugriff (PDF)

Accurate prediction of need for invasive treatment in alpha1-blocker treated patients with benign prostatic hyperplasia not possible : Bootstrap validation analysis

Urology (Ridgewood, N.J.), 2006-05, Vol.67 (5), p.984-989

2006

Volltextzugriff (PDF)

ACTH therapy of nephrotic syndrome

Maandschrift voor kindergeneeskunde, 1954-01, Vol.22 (1), p.20

1954

Volltextzugriff (PDF)

The actualization of leadership models adopted by field implementers that influencing the contractor employees' motivation and performance

Journal of Applied Engineering Science, 2019, Vol.17 (4), p.555-566

2019

Volltextzugriff (PDF)

Acute rejection in heart transplant patients is associated with the presence of committed donor‐specific cytotoxic lymphocytes in the graft but not in the blood

Clinical and experimental immunology, 1992-05, Vol.88 (2), p.213-219

1992

Volltextzugriff (PDF)

Adenocarcinoma mucinosum of extrophy bladder: A rare case report

International journal of surgery case reports, 2021-11, Vol.88, p.106493-106493, Article 106493

2021

Volltextzugriff (PDF)

Adenomyosis, Multiple, and Intraligamentery (Sacro Uterine) Fibroids: A Rare Case

Magna Medika (Online), 2023-10, Vol.10 (2), p.258-264

2023

Volltextzugriff (PDF)

Adherence of Indonesian urologists to practice guidelines for the management of benign prostatic hyperplasia

Prostate international, 2019-03, Vol.7 (1), p.35-40

2019

Volltextzugriff (PDF)

Age as a Risk Factor of Relapse Occurrence in Acute Lymphoblastic Leukemia-L1 (All-L1) in Children

American journal of clinical and experimental medicine (Print), 2015, Vol.3 (3), p.124

Mochtar, Yulianty

2015

Volltextzugriff (PDF)

Age, prostate volume, prostate-specific antigen and prostate-specific antigen density as predictor factors in results of transrectal ultrasonography-guided prostate biopsy [version 1; peer review: 1 approved with reservations]

F1000 research, 2019, Vol.8, p.875

2019

Volltextzugriff (PDF)

Age-related natural fertility outcomes in women over 35 years: a systematic review and individual participant data meta-analysis

Human reproduction (Oxford), 2020-08, Vol.35 (8), p.1808-1820

2020

Volltextzugriff (PDF)

1 – 25 von 696

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(541)
Mit Volltextzugriff
(560)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

120 Chemokine receptor engineering enhances trafficking and homing of primary and iPSC-derived CAR-T cells to solid tumors

1290: PSA Velocity in BPH: Characteristics and its Value to Predict BPH-Related Invasive Therapy

138 Synthetic re-direction of TGFβ receptors as a novel strategy to enhance the anti-tumor activity of CAR-T cells in solid tumors

1552: Surgical and Medical Retreatment Rates After Watchful Waiting in Patients With Luts Due to BPH

358 PERCUTANEOUS NEPHROLITHOTOMY USING SPINAL ANESTHESIA: SAFETY AND EFFICACY

415Large postvoid residual urine volumes: Does it affect clinical progression of treated and untreated BPH?

558 Results of a prospective study in 110 patients with lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH) using a nitinol thermo-expandable hour-glass shaped prostatic stent

559 The use of a nitinol thermo-expandable bell-shaped prostatic stent in benign prostatic hyperplasia (BPH): A feasibility study

Abstract 1497: A unique strategy to arm iPSC-derived CAR-T cells to perform antibody-directed cellular cytotoxicity to facilitate multi-antigen targeting

Abstract 1591: FT536: Preclinical development of a novel off-the-shelf CAR-MICA/B NK cell immunotherapy combined with radiation and antibody treatments as a first-of-kind pan-cancer targeting strategy

Abstract 2756: Multiplexed-engineered, iPSC-derived T cells expressing three unique targeting modalities address tumor heterogeneity and antigen escape

Abstract 2761: FT573: Preclinical development of multiplexed-engineered iPSC-derived NK cells expressing a novel camelid nanobody chimeric antigen receptor (CAR) targeting pan-cancer antigen B7-H3

Abstract 3245: FT819 path to IND: First-of-kind off-the-shelf CAR19 T-cell for B cell malignancies

Abstract LB-073: Generation of novel single cell-derived engineered master pluripotent cell line as a renewable source for off-the-shelf TCR-less CAR T cells in support of first-of-kind clinical trial

Accurate prediction of need for invasive treatment in alpha 1-blocker treated patients with benign prostatic hyperplasia not possible: Bootstrap validation analysis

Accurate prediction of need for invasive treatment in alpha1-blocker treated patients with benign prostatic hyperplasia not possible : Bootstrap validation analysis

ACTH therapy of nephrotic syndrome

The actualization of leadership models adopted by field implementers that influencing the contractor employees' motivation and performance

Acute rejection in heart transplant patients is associated with the presence of committed donor‐specific cytotoxic lymphocytes in the graft but not in the blood

Adenocarcinoma mucinosum of extrophy bladder: A rare case report

Adenomyosis, Multiple, and Intraligamentery (Sacro Uterine) Fibroids: A Rare Case

Adherence of Indonesian urologists to practice guidelines for the management of benign prostatic hyperplasia

Age as a Risk Factor of Relapse Occurrence in Acute Lymphoblastic Leukemia-L1 (All-L1) in Children

Age, prostate volume, prostate-specific antigen and prostate-specific antigen density as predictor factors in results of transrectal ultrasonography-guided prostate biopsy [version 1; peer review: 1 approved with reservations]

Age-related natural fertility outcomes in women over 35 years: a systematic review and individual participant data meta-analysis

Suchergebnisse filtern